Fibrocell Science, Inc. Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2019-09-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2019-09-30..
- Interest coverage · 12 months: Value 2.68×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2019-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2019-09-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2019-09-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | 2.68× | Operating income ÷ reported interest expense. $2.12M ÷ $793.00K ≈ 2.68× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 4.72M USD | Research and Development Expense |
| Revenue | (m) | |
| Stock-based compensation | 444.00K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 2.12M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 793.00K USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | $4.72M | (m) | $444.00K | $2.12M | $793.00K | (m) | (m) | 2.68× | Reported |
| 2019-06-30 | $5.50M | (m) | $495.00K | $3.38M | $787.00K | (m) | (m) | 4.29× | Reported |
| 2019-03-31 | $6.32M | $0.00 | $509.00K | $-13.27M | $778.00K | (m) | (m) | -17.05× | Reported |
| 2018-12-31 | $6.02M | $0.00 | $526.00K | $-12.39M | $771.00K | (m) | (m) | -16.07× | Reported |
| 2018-09-30 | $6.31M | $0.00 | $521.00K | $-14.07M | $762.00K | (m) | (m) | -18.46× | Reported |
| 2018-06-30 | $6.43M | $0.00 | $519.00K | $-15.56M | $841.00K | (m) | (m) | -18.50× | Reported |
| 2018-03-31 | $6.69M | $0.00 | $500.00K | $-17.51M | $835.00K | (m) | (m) | -20.97× | Reported |
| 2017-12-31 | $6.51M | $0.00 | $322.00K | $-18.98M | $828.00K | (m) | (m) | -22.92× | Reported |
| 2017-09-30 | $6.60M | $37.00K | $511.00K | $-18.55M | $823.00K | 17840.54% | 1381.08% | -22.54× | Reported |
| 2017-06-30 | $6.59M | $252.00K | $871.00K | $-18.97M | $596.00K | 2614.68% | 345.63% | -31.83× | Reported |
| 2017-03-31 | $7.26M | $339.00K | $1.34M | $-24.27M | $411.00K | 2142.18% | 394.99% | -59.04× | Reported |
| 2016-12-31 | $8.40M | $355.00K | $1.93M | $-26.48M | $228.00K | 2366.20% | 544.51% | -116.14× | Reported |
| 2016-09-30 | $9.36M | $400.00K | $2.10M | $-38.37M | $46.00K | 2339.75% | 526.00% | -834.02× | Reported |
| 2016-06-30 | $10.11M | $264.00K | $2.12M | $-40.17M | (m) | 3828.79% | 802.65% | (m) | (m) |
| 2016-03-31 | $10.32M | $314.00K | $2.34M | $-37.21M | (m) | 3287.90% | 746.18% | (m) | (m) |
| 2015-12-31 | $9.97M | $492.00K | $2.04M | $-37.41M | $0.00 | 2026.02% | 414.23% | (m) | Reported |
| 2015-09-30 | $1.64M | $466.00K | $1.78M | $-27.21M | (m) | 352.15% | 382.83% | (m) | (m) |
| 2015-06-30 | $2.32M | $407.00K | $1.54M | $-26.58M | (m) | 569.04% | 379.36% | (m) | (m) |
| 2015-03-31 | $2.67M | $328.00K | $1.18M | $-25.82M | (m) | 814.94% | 358.54% | (m) | (m) |
| 2014-12-31 | $8.34M | $180.00K | $1.24M | $-29.95M | (m) | 4634.44% | 688.33% | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | $-2.00K | (m) | (m) | (m) | Reported |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | $1.02M | (m) | (m) | (m) | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $7.17M | (m) | $2.90M | $-19.98M | $1.06M | (m) | (m) | -18.81× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.